1. Home
  2. AMAT vs NVO Comparison

AMAT vs NVO Comparison

Compare AMAT & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Materials Inc.

AMAT

Applied Materials Inc.

HOLD

Current Price

$295.94

Market Cap

213.6B

Sector

Technology

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$56.26

Market Cap

212.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMAT
NVO
Founded
1967
1923
Country
United States
Denmark
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6B
212.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMAT
NVO
Price
$295.94
$56.26
Analyst Decision
Buy
Buy
Analyst Count
27
11
Target Price
$236.85
$54.25
AVG Volume (30 Days)
6.2M
16.1M
Earning Date
02-12-2026
02-04-2026
Dividend Yield
0.65%
2.23%
EPS Growth
0.58
10.06
EPS
8.66
3.67
Revenue
$28,368,000,000.00
$49,580,393,058.00
Revenue This Year
$3.75
$7.25
Revenue Next Year
$13.35
$0.24
P/E Ratio
$32.83
$14.82
Revenue Growth
4.39
16.64
52 Week Low
$123.74
$43.08
52 Week High
$287.74
$93.80

Technical Indicators

Market Signals
Indicator
AMAT
NVO
Relative Strength Index (RSI) 74.06 70.49
Support Level $255.96 $50.55
Resistance Level $265.01 $53.63
Average True Range (ATR) 6.83 1.21
MACD 2.17 0.68
Stochastic Oscillator 95.48 81.99

Price Performance

Historical Comparison
AMAT
NVO

About AMAT Applied Materials Inc.

Applied Materials is the largest semiconductor wafer fabrication equipment manufacturer in the world. It has a broad portfolio spanning nearly every corner of the WFE ecosystem. Applied Materials holds leading market share in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: